Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GMED

Globus Medical Inc

Dec 13 • 04:00PM ET

82.42

Dollar change -0.29
Percentage change -0.35	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ SYK BSX ZBH BAX MEDP HOLX IART MTD TFX

| Held by: IJH VTI VB VXF VBK MDY IJJ IHI SCHA SPMD

Scroll to Statements

Index	-	P/E	124.33	EPS (ttm)	0.66	Insider Own	17.07%	Shs Outstand	113.47M	Perf Week	-1.08%
Market Cap	11.18B	Forward P/E	24.14	EPS next Y	3.41	Insider Trans	-1.45%	Shs Float	112.93M	Perf Month	-0.15%
Income	91.51M	PEG	8.83	EPS next Q	0.74	Inst Own	80.57%	Short Float	2.16%	Perf Quarter	17.79%
Sales	2.48B	P/S	4.51	EPS this Y	28.29%	Inst Trans	-3.42%	Short Ratio	2.92	Perf Half Y	25.62%
Book/sh	29.94	P/B	2.75	EPS next Y	14.73%	ROA	1.75%	Short Interest	2.44M	Perf Year	66.81%
Cash/sh	5.12	P/C	16.10	EPS next 5Y	14.07%	ROE	2.22%	52W Range	47.19 - 87.22	Perf YTD	54.66%
Dividend Est.	-	P/FCF	38.07	EPS past 5Y	-7.04%	ROI	2.20%	52W High	-5.50%	Beta	1.19
Dividend TTM	-	Quick Ratio	1.64	Sales past 5Y	18.43%	Gross Margin	53.40%	52W Low	74.66%	ATR (14)	1.66
Dividend Ex-Date	-	Current Ratio	2.51	EPS Y/Y TTM	-57.22%	Oper. Margin	7.31%	RSI (14)	52.47	Volatility	1.60% 1.97%
Employees	5000	Debt/Eq	0.13	Sales Y/Y TTM	102.10%	Profit Margin	3.69%	Recom	1.94	Target Price	93.23
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	4214.94%	Payout	0.00%	Rel Volume	1.16	Prev Close	82.71
Sales Surprise	3.48%	EPS Surprise	28.26%	Sales Q/Q	63.10%	Earnings	Nov 05 AMC	Avg Volume	837.53K	Price	82.42
SMA20	-1.48%	SMA50	4.97%	SMA200	22.25%	Trades		Volume	975,160	Change	-0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$83 → $100
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$60 → $78
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight	$60 → $80
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy	$60
Oct-20-23	Initiated	ROTH MKM	Buy	$75
Sep-19-23	Upgrade	Stifel	Hold → Buy	$61
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy	$67
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform	$83 → $63
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$67
Feb-10-23	Downgrade	Truist	Buy → Hold	$85 → $70
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Loop Capital	Buy → Hold	$90 → $70
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight	$69
Oct-12-22	Initiated	Jefferies	Buy	$75
Apr-13-22	Resumed	Truist	Buy	$80 → $91
Mar-28-22	Initiated	Wells Fargo	Overweight	$80
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$80 → $88
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy	$55 → $80
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$80

Show Previous Ratings

Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-05-24 12:00PM	What Makes Globus Medical (GMED) a New Buy Stock (Zacks)
11:30AM	Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Dec-02-24 02:21PM	Here's Why Globus Medical (GMED) is a Strong Value Stock (Zacks)
01:49PM	Loading…
01:49PM	Why Is Globus Medical, Inc. (GMED) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
Nov-29-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED) (Zacks)
Nov-22-24 04:30PM	Globus Medical Launches ExcelsiusHub Navigation System (GlobeNewswire)
09:15AM	Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-15-24 09:50AM	Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Nov-14-24 09:40AM	Why Globus Medical (GMED) is a Top Value Stock for the Long-Term (Zacks)
Nov-13-24 12:45PM	Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-12-24 06:50AM	Globus Medical price target raised to $83 from $74 at Morgan Stanley (TipRanks)
Nov-11-24 09:45AM	Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Nov-06-24 07:36AM	Q3 2024 Globus Medical Inc Earnings Call (Thomson Reuters StreetEvents) +9.43%
02:21AM	Loading…
02:21AM	Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
12:07AM	Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight (GuruFocus.com)
Nov-05-24 09:15PM	Globus Medical (GMED) Q3 2024 Earnings Call Transcript (Motley Fool)
06:00PM	Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates (Zacks)
04:33PM	Globus Medical: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Globus Medical Reports Third Quarter 2024 Results (GlobeNewswire)
Nov-03-24 01:38PM	Is a Globus Medical, Inc. (GMED) Promising Medical Stock with Growth Potential? (Insider Monkey)
Oct-31-24 09:15AM	Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-18-24 04:30PM	Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting (GlobeNewswire)
Oct-15-24 04:30PM	Globus Medical Schedules Third Quarter Earnings Release and Conference Call (GlobeNewswire)
07:37AM	Globus Medical price target raised to $78 from $77 at BTIG (TipRanks)
Oct-02-24 04:15PM	Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions (GlobeNewswire)
Sep-09-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino's and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-05-24 11:31AM	Why Is Globus Medical (GMED) Down 0.2% Since Last Earnings Report? (Zacks)
09:00PM	Loading…
Aug-30-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-22-24 08:15AM	Globus Medical's (GMED) Lateral Interbody Portfolio Gets New Launch (Zacks)
05:52AM	Globus Medical introduces ADIRA System for lateral plating (Medical Device Network)
Aug-21-24 04:15PM	Globus Medical Launches ADIRA XLIF Plate System (GlobeNewswire)
Aug-14-24 08:12AM	Globus receives warning letter over spine navigation robot (MedTech Dive)
Aug-09-24 09:50AM	Here's Why Globus Medical (GMED) is a Strong Momentum Stock (Zacks)
Aug-08-24 09:45AM	Here's Why Globus Medical (GMED) is a Strong Growth Stock (Zacks)
Aug-07-24 10:26AM	Globus Medical (GMED) Q2 Earnings Top Estimates, '24 View Up (Zacks)
09:50AM	Q2 2024 Globus Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 09:45PM	Globus Medical (GMED) Q2 2024 Earnings Call Transcript (Motley Fool)
06:00PM	Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:40PM	Globus Medical (GMED) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:34PM	Globus Medical: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Globus Medical Reports Second Quarter 2024 Results (GlobeNewswire)
Aug-05-24 09:16AM	Globus Medical (GMED) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Jul-19-24 10:37AM	Globus Medical (GMED) Global Sales, Innovation Aid Growth (Zacks)
Jul-18-24 09:34AM	Globus Medical (GMED) Gets FDA Nod for ExcelsiusFlex, ACTIFY 3D (Zacks)
04:52AM	Globus Medicals knee replacement technologies secure FDA clearance (Medical Device Network)
Jul-17-24 08:30AM	Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex and ACTIFY 3D Total Knee System (GlobeNewswire)
Jul-16-24 04:30PM	Globus Medical Schedules Second Quarter Earnings Release and Conference Call (GlobeNewswire)
Jul-12-24 09:45AM	Here's Why Globus Medical (GMED) is a Strong Growth Stock (Zacks)
09:15AM	Globus Medical, Inc. (GMED) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jul-10-24 09:40AM	Here's Why Globus Medical (GMED) is a Strong Value Stock (Zacks)
Jun-20-24 07:13AM	Globus Medical gets FDA nod for ortho robot (MedTech Dive)
Jun-17-24 09:50AM	Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term (Zacks)
Jun-14-24 09:45AM	Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term (Zacks)
Jun-06-24 11:31AM	Globus Medical (GMED) Up 7.4% Since Last Earnings Report: Can It Continue? (Zacks)
May-31-24 09:50AM	Here's Why Globus Medical (GMED) is a Strong Momentum Stock (Zacks)
09:29AM	Here's Why You Should Retain Globus Medical (GMED) Stock Now (Zacks)
May-23-24 08:51AM	Globus Medical (GMED) Hits 52-Week High: What's Driving It? (Zacks)
May-20-24 09:31AM	Rubrik and Marex Group initiated: Wall Street's top analyst calls (The Fly)
06:59AM	Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 (MT Newswires)
May-15-24 09:50AM	Here's Why Globus Medical (GMED) is a Strong Momentum Stock (Zacks)
May-14-24 05:24PM	Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing (MT Newswires)
May-13-24 07:07AM	Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating (MT Newswires)
May-10-24 04:52PM	Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing (MT Newswires)
May-09-24 11:57AM	Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating (MT Newswires)
09:15AM	Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? (Zacks)
07:58AM	Surgical robots are gift that will keep on giving, ortho firms say (MedTech Dive)
May-08-24 12:39PM	Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards (MT Newswires) +20.19%
11:32AM	Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:00AM	Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating (MT Newswires)
10:33AM	Globus Medical Up 23% As Q1 Results Beat Street; Raises FY Outlook (RTT News)
09:40AM	Why Globus Medical (GMED) is a Top Value Stock for the Long-Term (Zacks)
08:52AM	Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall (Zacks)
07:24AM	Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating (MT Newswires)
12:45AM	Globus Medical (GMED) Q1 2024 Earnings Call Transcript (Motley Fool)
May-07-24 06:00PM	Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:38PM	Globus Medical Q1 Non-GAAP Earnings, Sales Rise; 2024 Guidance Boosted (MT Newswires)
05:30PM	Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:32PM	Globus Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Globus Medical Reports First Quarter 2024 Results (GlobeNewswire)
May-06-24 09:15AM	Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings (Zacks)
Apr-16-24 04:30PM	Globus Medical Schedules First Quarter Earnings Release and Conference Call (GlobeNewswire)
Apr-15-24 09:50AM	Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-04-24 08:41AM	Globus Medical (GMED) Gains From New Launches Amid Macro Issues (Zacks)
Mar-24-24 03:50PM	From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires (InvestorPlace)
Mar-21-24 11:30AM	Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-13-24 04:30PM	7 Robotic Surgery Stocks to Buy for the Future of Healthcare (InvestorPlace) -6.29%
12:01PM	Here's Why You Should Retain Globus Medical (GMED) Stock Now (Zacks)
Feb-27-24 09:40AM	Here's Why Globus Medical (GMED) is a Strong Value Stock (Zacks)
Feb-26-24 09:50AM	Here's Why Globus Medical (GMED) is a Strong Momentum Stock (Zacks)
Feb-22-24 03:55AM	11 Best Small-Cap Growth Stocks to Invest In (Insider Monkey)
Feb-21-24 11:45AM	Q4 2023 Globus Medical Inc Earnings Call (Thomson Reuters StreetEvents)
09:45AM	Globus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:13AM	Globus Medical (GMED) Q4 Earnings Surpass, Margins Down (Zacks)
Feb-20-24 08:30PM	Globus Medical (GMED) Q4 2023 Earnings Call Transcript (Motley Fool)
07:00PM	Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics (Zacks)
05:30PM	Globus Medical (GMED) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:54PM	Globus Medical Inc (GMED) Posts Record Sales Amid NuVasive Merger, Despite Net Income Dip (GuruFocus.com)

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Huller Kelly	SVP, GC, Corporate Secretary	Dec 02 '24	Option Exercise	24.21	2,500	60,525	2,500	Dec 04 04:12 PM
Huller Kelly	SVP, GC, Corporate Secretary	Dec 02 '24	Sale	87.00	2,500	217,502	0	Dec 04 04:12 PM
Huller Kelly	Officer	Dec 02 '24	Proposed Sale	86.95	2,500	217,364		Dec 02 04:35 PM
Davidar David D	Director	Nov 21 '24	Sale	85.00	13,254	1,126,590	172,713	Nov 25 04:35 PM
Davidar David D	Director	Nov 21 '24	Sale	85.00	13,234	1,124,890	523,041	Nov 25 04:35 PM
Davidar David D	Director	Nov 22 '24	Sale	85.00	6,766	575,135	516,275	Nov 25 04:35 PM
Davidar David D	Director	Nov 22 '24	Sale	85.00	6,746	573,435	165,967	Nov 25 04:35 PM
Lemaitre Dan	Director	Nov 21 '24	Option Exercise	65.05	13,278	863,734	13,278	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 22 '24	Option Exercise	65.05	1,097	71,360	1,097	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 21 '24	Sale	85.00	13,278	1,128,630	0	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 22 '24	Sale	85.02	1,097	93,263	0	Nov 25 04:31 PM
Scavilla Daniel T	President, CEO	Nov 21 '24	Option Exercise	43.65	130,000	5,674,900	130,000	Nov 25 04:29 PM
Scavilla Daniel T	President, CEO	Nov 21 '24	Sale	85.00	130,000	11,050,000	0	Nov 25 04:29 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	85.00	20,000	1,700,000		Nov 21 07:12 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	0.85	20,000	17,000		Nov 21 07:04 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	84.95	3,500	297,311		Nov 21 06:54 PM
Lemaitre Dan	Director	Nov 21 '24	Proposed Sale	85.00	14,375	1,221,875		Nov 21 06:05 PM
Scavilla Daniel T	Officer	Nov 21 '24	Proposed Sale	84.95	130,000	11,043,000		Nov 21 04:31 PM
Paul David C	Executive Chairman	Nov 15 '24	Option Exercise	24.10	26,042	627,612	26,042	Nov 20 04:15 PM
Scavilla Daniel T	President, CEO	Nov 06 '24	Option Exercise	35.02	60,000	2,101,200	60,000	Nov 08 04:23 PM
Scavilla Daniel T	President, CEO	Nov 06 '24	Sale	80.02	60,000	4,801,200	0	Nov 08 04:23 PM
Huller Kelly	SVP, GC, Corporate Secretary	Nov 06 '24	Option Exercise	24.21	5,000	121,050	5,000	Nov 08 04:21 PM
Huller Kelly	SVP, GC, Corporate Secretary	Nov 06 '24	Sale	81.01	5,000	405,050	0	Nov 08 04:21 PM
Scavilla Daniel T	Officer	Nov 06 '24	Proposed Sale	79.97	60,000	4,798,000		Nov 06 03:41 PM
Huller Kelly	Officer	Nov 06 '24	Proposed Sale	81.00	5,000	405,000		Nov 06 03:25 PM
Huller Kelly	SVP, GC, Corporate Secretary	Oct 16 '24	Option Exercise	25.80	7,500	193,500	7,500	Oct 18 04:39 PM
Davidar David D	Director	Oct 16 '24	Sale	75.04	30,000	2,251,203	536,275	Oct 18 04:23 PM
Davidar David D	Director	Oct 16 '24	Sale	75.03	20,000	1,500,610	185,967	Oct 18 04:23 PM
Huller Kelly	Officer	Oct 16 '24	Proposed Sale	74.97	7,500	562,250		Oct 16 03:46 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	74.96	3,500	262,350		Oct 16 03:41 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	75.00	20,000	1,500,000		Oct 16 03:33 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	75.00	30,000	2,250,000		Oct 16 03:22 PM
RHOADS ANN D	Director	Sep 13 '24	Option Exercise	24.91	35,000	871,900	57,884	Sep 17 04:34 PM
RHOADS ANN D	Director	Sep 13 '24	Sale	70.36	15,000	1,055,400	42,884	Sep 17 04:34 PM
Davidar David D	Director	Sep 13 '24	Option Exercise	25.52	25,000	638,000	591,275	Sep 17 04:31 PM
Davidar David D	Director	Sep 13 '24	Sale	70.46	25,000	1,761,500	566,275	Sep 17 04:31 PM
RHOADS ANN D	Director	Sep 13 '24	Proposed Sale	70.33	15,000	1,055,000		Sep 13 04:03 PM
Davidar David D	Director	Sep 13 '24	Proposed Sale	70.47	25,000	1,761,780		Sep 13 03:55 PM
Norwalk Leslie V	Director	Jul 11 '24	Sale	70.00	1,000	70,000	16,419	Jul 15 04:25 PM
Lemaitre Dan	Director	May 10 '24	Option Exercise	46.87	52,500	2,460,850	63,300	May 14 05:16 PM
Lemaitre Dan	Director	May 10 '24	Sale	64.61	63,300	4,090,022	0	May 14 05:16 PM
Davidar David D	Director	May 08 '24	Sale	65.00	20,000	1,300,000	566,275	May 10 04:48 PM
Norwalk Leslie V	Director	Mar 15 '24	Sale	51.99	10,590	550,574	17,419	Mar 19 07:40 PM
Huller Kelly	SVP, GC, Corporate Secretary	Mar 01 '24	Option Exercise	24.90	7,500	186,750	7,500	Mar 05 05:07 PM
Huller Kelly	SVP, GC, Corporate Secretary	Mar 01 '24	Sale	54.10	7,500	405,730	0	Mar 05 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GMED

Globus Medical Inc

Upgrade your FINVIZ experience